开发和可解释的人工智能驱动的预后模型的预后模型的AI驱动的表征,以表现出 haploidentical 移植结果
Rohtesh S Mehta1, Yosra M Aljawai2, Partow Kebriaei2
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rmehta1@mdanderson.org.
NPJ digital medicine
|March 2, 2026
概括
这项研究引入了一种AI模型,用于预测单一血型细胞移植 (HCT) 后的生存率. 考虑年龄和HLA匹配的最佳供体选择,可以显著改善患者的治疗结果.
科学领域:
- 造血干细胞移植 造血干细胞移植
- 人工智能在医学中的应用
- 预测建模的预测建模
背景情况:
- 使用移植后环酸胺 (PTCy) 的哈普罗特异性造血细胞移植 (HCT) 是一个不断发展的领域.
- 在HCT中确定总生存期 (OS) 的关键预后因素对于患者管理至关重要.
- 现有的模型可能无法完全捕捉出供体和受体因素的复杂相互作用.
研究的目的:
- 开发和验证一种新的,可解释的人工智能 (AI) 驱动的预后模型,用于全息相同的HCT的整体生存.
- 定义等级并量化预后因素的影响,包括捐赠者/接受者特征和HLA匹配.
- 为个性化供体选择提供数据驱动的框架,以优化HCT结果.
主要方法:
- 开发一种可解释的AI模型 (梯度提升机),使用来自668名患者的当代数据,这些患者接受了与PTCy相同的HCT.
- 应用可解释的AI技术 (部分依赖图,替代决策树) 来识别非线性关系和因素重要性.
- 将患者分为风险四分位数的分层和模拟分析,以评估优化供体选择的影响.
主要成果:
- 接受者的年龄成为主要的风险因素,由捐赠者的年龄和HLA因素调节.
- 观察到捐赠者年龄的非线性U形效应,20岁末至40岁初的捐赠者获得最佳结果.
- HLA-DPB1非容许性不匹配是影响3年生存期最重要的HLA因子,其次是HLA-B领导者和HLA-DQB1不匹配.
结论:
- 人工智能模型准确地将患者分为不同的风险组,在3年的生存期中存在显著差异.
- 优化基于年龄和HLA匹配的供体选择可以显著改善患者的风险概况和生存率.
- 这项研究提供了一种实用,人工智能驱动的方法,用于现代HCT中个性化供体选择,保证多中心验证.
相关概念视频
01:21Hematopoiesis
9.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.4K
01:01Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
01:21Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K
01:19Multipotency of Hematopoietic Stem Cells
4.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K
01:22Bone Marrow Sampling and Transplants
1.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.9K